IT1193145B - Derivato del carbostirile procedimento per la sua preparazione e composizione farmaceutica contenente tale derivato - Google Patents
Derivato del carbostirile procedimento per la sua preparazione e composizione farmaceutica contenente tale derivatoInfo
- Publication number
- IT1193145B IT1193145B IT67922/83A IT6792283A IT1193145B IT 1193145 B IT1193145 B IT 1193145B IT 67922/83 A IT67922/83 A IT 67922/83A IT 6792283 A IT6792283 A IT 6792283A IT 1193145 B IT1193145 B IT 1193145B
- Authority
- IT
- Italy
- Prior art keywords
- derivatives
- preparation
- pharmaceutical composition
- composition containing
- carbostyril derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15409082A JPS5962585A (ja) | 1982-09-03 | 1982-09-03 | カルボスチリル誘導体 |
JP57213167A JPS59104378A (ja) | 1982-12-03 | 1982-12-03 | カルボスチリル誘導体 |
JP58114679A JPS606685A (ja) | 1983-06-24 | 1983-06-24 | カルボスチリル誘導体 |
Publications (2)
Publication Number | Publication Date |
---|---|
IT8367922A0 IT8367922A0 (it) | 1983-09-05 |
IT1193145B true IT1193145B (it) | 1988-06-02 |
Family
ID=27312797
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT67922/83A IT1193145B (it) | 1982-09-03 | 1983-09-05 | Derivato del carbostirile procedimento per la sua preparazione e composizione farmaceutica contenente tale derivato |
Country Status (11)
Country | Link |
---|---|
US (1) | US4564619A (it) |
KR (1) | KR910000181B1 (it) |
CA (1) | CA1252469A (it) |
CH (1) | CH655110A5 (it) |
DE (1) | DE3331808A1 (it) |
ES (4) | ES8502686A1 (it) |
FR (1) | FR2532648B1 (it) |
GB (1) | GB2127402B (it) |
IT (1) | IT1193145B (it) |
NL (1) | NL8303066A (it) |
SE (1) | SE455503B (it) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT80533B (en) * | 1984-05-29 | 1987-04-06 | Pfizer | Process for preparing quinolone inotropic agents |
GB8529362D0 (en) * | 1985-11-28 | 1986-01-02 | Pfizer Ltd | Quinolone cardiac stimulants |
DK167187A (da) * | 1986-04-02 | 1987-10-03 | Otsuka Pharma Co Ltd | Carbostyrilderivater og salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse |
KR940000785B1 (ko) * | 1986-04-02 | 1994-01-31 | 오오쓰까세이야꾸 가부시끼가이샤 | 카르보스티릴 유도체 및 그의 염의 제조 방법 |
KR100305515B1 (ko) * | 1999-02-04 | 2001-09-24 | 이순금 | 메주의 제조방법 |
NL1012886C1 (nl) | 1999-08-23 | 2001-02-26 | Rephartox | 1,4-Dihydropyridine-5-carbonzuuresterderivaten en werkwijze voor de bereiding ervan. |
KR100422242B1 (ko) * | 2001-07-20 | 2004-03-12 | 농업회사법인(주)맛가마식품 | 중공봉형상 메주와 이를 이용한 간장 및 된장 제조방법과제조용 장독 |
US20070066619A1 (en) * | 2002-10-07 | 2007-03-22 | Artesian Therapeutics, Inc. | Compounds having simultaneous ability to block L-type calcium channels and to inhibit phosphodiesterase type 3 activity |
PL376405A1 (en) * | 2002-10-07 | 2005-12-27 | Artesian Therapeutics, Inc. | Dihydropyridine compounds having simultaneous ability to block l-type calcium channels and to inhibit phosphodiesterase type 3 activity |
NL1028564C2 (nl) * | 2005-03-17 | 2006-09-20 | Rademaker Holding B V | Toepassing van een coumarine-groep omvattende derivaten voor de bereiding van een antiviraal middel, coumarine-group omvattende derivaten, een werkwijze voor de bereiding daarvan, en farmaceutische preparaten die deze bevatten. |
EP2275095A3 (en) | 2005-08-26 | 2011-08-17 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
EP2258358A3 (en) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
JP2009512711A (ja) | 2005-10-21 | 2009-03-26 | ブレインセルス,インコーポレイティド | Pde阻害による神経新生の調節 |
CA2625210A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
AU2007223036A1 (en) * | 2006-03-08 | 2007-09-13 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
US20100216734A1 (en) * | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
AU2007249435A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | 5 HT receptor mediated neurogenesis |
WO2007134136A2 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
US20100009983A1 (en) * | 2006-05-09 | 2010-01-14 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
KR20090064418A (ko) * | 2006-09-08 | 2009-06-18 | 브레인셀즈 인코퍼레이션 | 4-아실아미노피리딘 유도체 포함 조합물 |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
WO2008036678A2 (en) * | 2006-09-19 | 2008-03-27 | Braincells, Inc. | Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis |
WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
US20150119399A1 (en) | 2012-01-10 | 2015-04-30 | President And Fellows Of Harvard College | Beta-cell replication promoting compounds and methods of their use |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3971797A (en) * | 1973-06-15 | 1976-07-27 | Merck & Co., Inc. | S,S'-bis(pyridylmethyl)-carbonodithioates |
DE2508181A1 (de) * | 1975-02-26 | 1976-09-09 | Bayer Ag | 1,4-dihydropyridincarbonsaeurearal- kylester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
US4081447A (en) * | 1975-04-09 | 1978-03-28 | Abbott Laboratories | 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof |
DE2659665A1 (de) * | 1976-12-30 | 1978-07-13 | Nattermann A & Cie | Neue 1,4-dihydropyridin-derivate |
JPS5387368A (en) * | 1977-01-12 | 1978-08-01 | Otsuka Pharmaceut Co Ltd | Carbostyril derivative |
JPS5390270A (en) * | 1977-01-14 | 1978-08-08 | Otsuka Pharmaceut Co Ltd | Carbostryl derivs. |
IE46852B1 (en) * | 1977-06-10 | 1983-10-05 | Otsuka Pharma Co Ltd | Novel carbostyril derivatives |
DE2805404A1 (de) * | 1978-02-09 | 1979-08-16 | Merck Patent Gmbh | 1-aryloxy-3-nitratoalkylamino-2-propanole und verfahren zu ihrer herstellung |
IT1097538B (it) * | 1978-07-17 | 1985-08-31 | Medea Res Srl | Processo per la preparazione del 2,6-dimetil-4-3(3-nitrofenil)-3-metossicarbonil-1,4-didropiridin-5-carbossilati di 2(n-benzil-n-metilammino) |
CA1117117A (en) * | 1978-10-10 | 1982-01-26 | Fujisawa Pharmaceutical Co., Ltd. | 2-methyl-dihydropyridine compound, processes for preparation thereof and pharmaceutical composition comprising the same |
DE3034237A1 (de) * | 1979-09-18 | 1981-04-16 | Otsuka Pharmaceutical Co. Ltd., Tokyo | Carbostyrilderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende, antihistaminisch wirkende mittel |
PH17194A (en) * | 1980-03-06 | 1984-06-19 | Otsuka Pharma Co Ltd | Novel carbostyril derivatives,and pharmaceutical composition containing the same |
JPS5777676A (en) * | 1980-10-31 | 1982-05-15 | Otsuka Pharmaceut Co Ltd | Carbostyril derivative |
JPS57200386A (en) * | 1981-06-04 | 1982-12-08 | Yoshitomi Pharmaceut Ind Ltd | Novel 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its salts |
-
1983
- 1983-09-01 CH CH4807/83A patent/CH655110A5/de not_active IP Right Cessation
- 1983-09-02 SE SE8304737A patent/SE455503B/sv not_active IP Right Cessation
- 1983-09-02 ES ES525346A patent/ES8502686A1/es not_active Expired
- 1983-09-02 DE DE19833331808 patent/DE3331808A1/de not_active Withdrawn
- 1983-09-02 US US06/528,887 patent/US4564619A/en not_active Expired - Fee Related
- 1983-09-02 KR KR1019830004144A patent/KR910000181B1/ko not_active IP Right Cessation
- 1983-09-02 NL NL8303066A patent/NL8303066A/nl not_active Application Discontinuation
- 1983-09-02 CA CA000435962A patent/CA1252469A/en not_active Expired
- 1983-09-02 FR FR8314115A patent/FR2532648B1/fr not_active Expired
- 1983-09-02 GB GB08323542A patent/GB2127402B/en not_active Expired
- 1983-09-05 IT IT67922/83A patent/IT1193145B/it active
-
1984
- 1984-05-16 ES ES532538A patent/ES532538A0/es active Granted
- 1984-05-16 ES ES532536A patent/ES8505998A1/es not_active Expired
- 1984-05-16 ES ES532537A patent/ES8601187A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
KR850000402A (ko) | 1985-02-27 |
NL8303066A (nl) | 1984-04-02 |
FR2532648A1 (fr) | 1984-03-09 |
ES8506697A1 (es) | 1985-07-16 |
ES525346A0 (es) | 1985-01-16 |
CH655110A5 (de) | 1986-03-27 |
CA1252469A (en) | 1989-04-11 |
ES532537A0 (es) | 1985-10-16 |
GB8323542D0 (en) | 1983-10-05 |
GB2127402A (en) | 1984-04-11 |
ES8601187A1 (es) | 1985-10-16 |
SE455503B (sv) | 1988-07-18 |
ES532538A0 (es) | 1985-07-16 |
SE8304737D0 (sv) | 1983-09-02 |
KR910000181B1 (ko) | 1991-01-21 |
FR2532648B1 (fr) | 1989-07-21 |
US4564619A (en) | 1986-01-14 |
ES532536A0 (es) | 1985-06-16 |
ES8502686A1 (es) | 1985-01-16 |
GB2127402B (en) | 1987-01-14 |
IT8367922A0 (it) | 1983-09-05 |
ES8505998A1 (es) | 1985-06-16 |
DE3331808A1 (de) | 1984-03-08 |
SE8304737L (sv) | 1984-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT1193145B (it) | Derivato del carbostirile procedimento per la sua preparazione e composizione farmaceutica contenente tale derivato | |
IT1144315B (it) | Derivati carbostirilici procedimento per la loro preparazione e composizioni farmaceutiche contenenti tali derivati | |
IT8168566A0 (it) | Complesso antibiotico procedimento per la sua preparazione composizione farmaceutica contenente tale complesso e microorganismo per l attuazione di tale procedimento | |
DK257485D0 (da) | Farmaceutiske praeparater til oral indgift | |
IT1196048B (it) | Derivati della tiazolina,procedimento per la loro preparazione e loro composizioni farmaceutiche | |
PT82985A (pt) | Process for the preparation of distamycin derivatives and of pharmaceutical compositions containing the same | |
IT8422785A1 (it) | Derivati del benzossazolone e del benzotiazolone, procedimenti per la loro preparazione e composizione farmaceutica che li contiene | |
IT1224226B (it) | Derivati benzofuranici procedimento per la loro preparazione e composizioni farmaceutiche e cosmetiche che li comprendono | |
IT1169969B (it) | Derivati del 7-carbossimetossifenilacetammido-3-cefeme, procedimenti per la loro preparazione e preparazioni antibatteriche che li contengono | |
IT1170307B (it) | Derivati cefalosporinici e procedimento per la loro preparazione | |
IT1205665B (it) | Derivati 1-(idrossistiril)-5h2,3-benzodiazepinici,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono | |
IT1129933B (it) | Derivati tioetilammidici loro composizioni farmaceutiche e procedimento per la loro preparazione | |
PT87024A (pt) | Process for the preparation of propiolophenone derivatives and of pharmaceutical compositions containing the same | |
IT1195267B (it) | Derivati teofillinmetildiossolanici,procedimento per la loro preparazione e relative composizioni farmaceutiche | |
IT1190426B (it) | Derivati del flavolignano,procedimento per la loro preparazione e medicinali che contengono questi composti | |
IT8248970A0 (it) | Derivati xantinici, procedimento per la loro preparazione, composizione farmaceutiche che li contengono e loro impiego terapeutico | |
IT8667976A0 (it) | Derivati teofillinmetilditiolanici e teofillinmetilditianici procedimento per la loro preparazione e composizioni farmaceutiche che li comprendono | |
IT1193590B (it) | Derivati amino-alchil-solfonici,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono | |
IT1171361B (it) | Amminociclopentanon-ammidi e procedimento per la loro preparazione e formulazione farmaceutica | |
IT1168766B (it) | Derivati di piperazina e di omopipe razina,procedimenti per la loro preparazione e composizioni farmaceutiche che li contengono | |
IT1129305B (it) | Derivati di 1,2,4 ossadiazolin 5 one procedimento per la loro preparazione e composizioni farmaceutiche che li contengono | |
IT1243203B (it) | Derivati aminopropanolici, procedimenti per la loro preparazione e composizioni farmaceutiche che li contengono | |
IT1218322B (it) | Derivati di 1,2,3,4-tetraidronaftalene,procedimento di preparazione e relative composizioni farmaceutiche | |
IT1156515B (it) | Composto terapeutico antiipertensivo procedimento per la sua preparazione e composizioni farmaceutiche contenenti tale composto | |
IT8050258A0 (it) | Composizione farmaceutica antitumorale e procedimento per la sua preparazione |